Literature DB >> 18773624

Sexual dysfunction as a complication of treatment of gestational trophoblastic neoplasia.

Ma Stephanie Fay S Cagayan1.   

Abstract

OBJECTIVE: To examine the impact of gestational trophoblastic neoplasia (GTN) therapy on women's sexuality. STUDY
DESIGN: A questionnaire concerning various sexual problems experienced by patients treated with chemotherapy and/or surgery for GTN and in remission for 1 year or more was completed by 47 women in the outpatient clinic of the Trophoblastic Disease Section of our institution from January to June 2007.
RESULTS: Ninety-five percent of the subjects continued sexual activity after treatment, but there was an increase in the incidence of sexual problems, which resulted in a slight reduction in the quality of their sex lives. Seventy percent of the women experienced absent or low sexual desire, while 42% had dyspareunia and 45% had lubrication problems. Fifty-three percent experienced changes in the relationship with their partner within the first year after remission.
CONCLUSION: Sexual dysfunction is a common complication of treatment of GTN yet is given little attention as compared to other complications. Patient education and reassurance, with early diagnosis and intervention, are essential for a better quality of life for survivors.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18773624

Source DB:  PubMed          Journal:  J Reprod Med        ISSN: 0024-7758            Impact factor:   0.142


  2 in total

1.  Association of ß-hCG Surveillance with Emotional, Reproductive, and Sexual Health in Women Treated for Gestational Trophoblastic Neoplasia.

Authors:  Elizabeth L Jewell; Carol Aghajanian; Margaret Montovano; Sharyn N Lewin; Raymond E Baser; Jeanne Carter
Journal:  J Womens Health (Larchmt)       Date:  2017-12-21       Impact factor: 2.681

2.  Current chemotherapeutic management of patients with gestational trophoblastic neoplasia.

Authors:  Taymaa May; Donald P Goldstein; Ross S Berkowitz
Journal:  Chemother Res Pract       Date:  2011-05-11
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.